The Board of Directors has appointed Dr. Masoud Abedini as the new Chief Executive Officer of Atra Zist Aray Company, effective from the beginning of April 2026 (Farvardin 1405).

According to the company’s Public Relations Department, Dr. Abedini—a pharmacist and one of the seasoned executives of the national pharmaceutical industry—brings extensive experience in sales, marketing, commercial operations, and executive management across several pharmaceutical companies.

With his managerial background and hands‑on operational expertise, Dr. Abedini is expected to accelerate the development of the company’s product portfolio, enhance supply‑chain processes, and improve operational efficiency. His leadership is anticipated to support the effective implementation of Atra Zist Aray’s strategic plans for 2026.

In its appointment statement, the Board emphasized Dr. Abedini’s influential role in market development, quality enhancement, and strengthening collaboration with stakeholders across the pharmaceutical ecosystem. The Board expressed confidence that his leadership will open a new chapter in the company’s growth and advancement.